Tue, Sep 2, 2014, 5:14 AM EDT - U.S. Markets open in 4 hrs 16 mins

Recent

% | $
Quotes you view appear here for quick access.

Cyclacel Pharmaceuticals, Inc. (CYCC) Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • jakjohneson jakjohneson Dec 6, 2012 6:41 PM Flag

    SEEKING ARTICLE ON NOV 1ST SAYS 7 DIED. LOOK AT CHART NOV 1ST PLUMMETTED.

    Dude,

    You are an idiot. All patients would have dies within two months without any treatment. Do your research; they were the walking dead that didn't respond to other therapies. Not only did they have old age against them, they were in their late 70's, but they also had AML which left them and their immune systems totally ravaged.
    7died out of 100, not too bad. I'd take that risk if I was going to be dead in the next two to three months. I'd take 7 out of 20 if I had two months to live.
    Two million shares traded yesterday by short term traders who took their profits today.
    They may mark the stock down tomorrow with the hopes that if the news isn't spectacular then the stock will get pounced on by shorts and long sellers. Problem is, there isn't that many shares to short.
    If the survival rate carries through, and there is a very good chance it does, then you will be covering or trying to short more shares 4 to 8 points higher.
    If the news is good, expect funds to start buying the stock and taking it up into the 20's over the next few months.
    Then expect a partnership, for another 4 points added to the stock, and eventually an FDA approval. See you at 50, and I hope you're still short your few hundred shares so it will cost you $10,000.00 to cover for being an idiot.

 
CYCC
3.48-0.01(-0.29%)Aug 29 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Exelixis, Inc.
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT
Criteo SA
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT